TY  - JOUR
AU  - Fernandez-Navarro, Pablo L
AU  - López-Nieva, Pilar
AU  - Piñeiro-Yañez, Elena
AU  - Carreno-Tarragona, Gonzalo
AU  - Martinez-López, Joaquín
AU  - Sánchez Pérez, Raúl
AU  - Aroca, Ángel
AU  - Al-Shahrour, Fatima
AU  - Cobos-Fernández, María Ángeles
AU  - Fernández-Piqueras, José
PY  - 2019
DO  - 10.1186/s12885-019-6209-9
SN  - 1471-2407
UR  - http://hdl.handle.net/20.500.12105/9095
AB  - BACKGROUND: Acute T-cell lymphoblastic leukaemia (T-ALL) is an aggressive disorder derived from immature thymocytes. The variability observed in clinical responses on this type of tumours to treatments, the high toxicity of current protocols and the...
LA  - eng
PB  - BioMed Central (BMC)
KW  - Cancer genomics
KW  - Druggable genome
KW  - In silico prescription
KW  - Next-generation sequencing technologies
KW  - PanDrugs
KW  - Personalized precision medicine
KW  - Precision oncology
KW  - T-ALL
KW  - Targeted therapy
KW  - Translational bioinformatics
TI  - The use of PanDrugs to prioritize anticancer drug treatments in a case of T-ALL based on individual genomic data
TY  - journal article
ER  -